ClinConnect ClinConnect Logo
Search / Trial NCT05608590

What is the Best Moment for Performing an HSG in Women With a Unfulfilled Childwish

Launched by AMSTERDAM UMC, LOCATION VUMC · Oct 31, 2022

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Infertility Fallopian Tubes Hysterosalpingography Tubal Flushing Pregnancy Live Birth Cost Effectiveness Randomized Controlled Trial

ClinConnect Summary

This clinical trial is looking at the best timing for a specific procedure called HSG (hysterosalpingography) in women who are trying to get pregnant but have not yet succeeded. The trial aims to find out if performing the HSG procedure right away, using a special type of contrast fluid, can lead to more ongoing pregnancies and help women conceive faster compared to waiting six months after their fertility tests are done. The researchers believe that this approach may be both effective and cost-effective for women who are less likely to have problems with their fallopian tubes.

To be eligible for this trial, women need to be between 18 and 39 years old, have regular menstrual cycles, and be undergoing fertility evaluations. However, those with certain health issues like hormone disorders or allergies to iodine, as well as men with low sperm counts, cannot participate. Women who join the trial can expect to receive care and follow-up regarding their fertility while helping researchers learn more about the best practices for improving pregnancy chances.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women between 18-39 years of age
  • Spontaneous menstrual cycle
  • Perceived low risk for tubal pathology
  • Undergoing fertility work-up
  • Exclusion Criteria:
  • Women with known endocrine disorders (e.g. the polycystic ovary syndrome, diabetes, hyperthyroidism and hyperprolactinemia. Except for well managed hypothyroidism with TSH between 0.3 and 2.5mIU/l)
  • Ovulation disorders defined as less than eight menstrual cycles per year
  • Iodine allergy
  • Male subfertility defined as a post-wash total motile sperm count \< 1 x10\^6 spermatozoa/ml
  • Not willing or able to sign the consent form

About Amsterdam Umc, Location Vumc

Amsterdam UMC, located at VU Medical Center (VUmc), is a leading academic medical center in the Netherlands dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on translating scientific discoveries into practical applications, Amsterdam UMC collaborates closely with researchers, healthcare professionals, and industry partners to enhance patient outcomes. The institution is committed to rigorous ethical standards and regulatory compliance, ensuring the integrity and reliability of its clinical research initiatives across various medical disciplines.

Locations

Amsterdam, , Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials